April 25, 2007 - Alpharma Inc., a global specialty pharmaceutical company, announced that it has received FDA clearance for the KADIAN 10mg strength capsule. The company expects to launch this new dosage strength in 2007.
This is the second FDA approval for a KADIAN line extension in 2007. In March, the company received FDA approval for a 200mg dosage strength which was launched in April 2007. KADIAN is Alpharma's branded extended release morphine sulfate product and is currently marketed in 20mg, 30mg, 50mg, 60mg, 80mg, 100mg and 200mg dosage strengths.